A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Clinical trial NCT05932290 · COMPLETED
Trial details
- NCT number
- NCT05932290
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-01
- Primary completion
- 2023-07-12
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.